Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Minty_33on Dec 14, 2020 9:43pm
123 Views
Post# 32106248

RE:RE:RE:RE:RE:RE:RE:RE:RE:AGN halted

RE:RE:RE:RE:RE:RE:RE:RE:RE:AGN halted"There are many players in beta glucan, etc., that might try to catch up as soon as CZO shows the world what they have"

And so you're saying that with all the heart healthy positives regarding beta glucan, not one of these many players as you say, thought about doing a similar test similar to what the MHI is doing? Highly doubtful. 

The fact that this company has a serious IR and communication problem is disturbing, so much so that a previous BNN analyst advised that they should be a private company. As well, seeing that they haven't INKED one deal with all the Billion Dollar markets they tout to potentially have access to is unacceptable. They have put out the new invester presentation which puts a date on a out licencing deal. Let's see if their money and mouths are alligned. This should be INTERESTING.... as word that Gilles uses quite a bit. 







<< Previous
Bullboard Posts
Next >>